Patent · US Active

Oral controlled release dosage form

US8252327B2 · kind B2 · utility

0Cited by

40References

13Claims

0Family size

Assignee

Andrx Pharmaceuticals, Inc. · US

Inventors

Manesh Dixit · Sunrise, US
Chih-Ming Chen · Taipei, TW
Xiu Xiu Cheng · Pembroke Pines, US
Jianbo Xie · Lo Wu, CN

Key dates

Filing date	Jul 11, 2011
Grant date	Aug 28, 2012
Priority date	—
Expiry date	Jul 11, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.